| iQone Healthcare Switzerland SA - Remsima 100 mg, solution à diluer pour perfusion |
| 70236 | | 01 | | Remsima 100 mg | | solution à diluer pour perfusion | | L04AB02 | | Infliximab | | 06.07.2026 | | |
|
| Composition |
| infliximabum 100 mg, acidum aceticum, natrii acetas trihydricus corresp. natrium max. 0.63 mg, sorbitolum 112.5 mg, polysorbatum 80 1.3 mg, aqua ad iniectabile ad solutionem pro 2.5 ml. |
| Packungsbestandteile |
| Concentrate for infusion | | | | | | Active Agent | Dose |
|---|
| Infliximab | 100mg / 2.5ml |
| | | | Inactive agents | Dose |
|---|
| Acetic Acid | | | Natrii Acetas Trihydricus | | | Polysorbatum 80 | 1.3mg / 2.5ml | | Sorbitol | 112.5mg / 2.5ml |
|
|
| Package number | Package Size | EFP | CP | Category | SL | Out of trade (MedRef) |
|---|
| 001 | | | | A | | No |
|
